É necessária uma assinatura da JoVE para visualizar este conteúdo. Faça login ou comece sua avaliação gratuita.
This video explains the concept of CRISPR-mediated cytosine base editors for inducing targeted nucleotide substitution.
1. Creation of BRCA1 variants using CRISPR-mediated base editing tools
NOTE: If HAP1-BE3 cell lines is not used, BE3-encoding plasmid DNA can be co-transfected with BRCA1-targeting gRNA. Compared to co-transfection of BE3 and gRNA plasmids, transfection of gRNA plasmid to HAP-BE3 cells induce efficient base editing up to 3-fold at target locus in our hands.
Name | Company | Catalog Number | Comments |
Lipofectamine 2000 | Thermo Fisher Scientific | 11668027 | Transfection reagent |
Opti-MEM | Gibco | 31985070 | Transfection materials |
FuGENE HD Transfection Reagent | Promega | E2311 | Transfection reagent |
Iscove’s modified Dulbecco’s medium | Gibco | 12440046 | Medium for HAP1 cells |
lentiCas9-Blast | Addgene | 52962 | Plasmids DNA for lentiBE3 cloning |
DNeasy Blood & Tissue Kit | Qiagen | 69504 | Genomic DNA prep. kit |
This article has been published
Video Coming Soon
Source: See, J. E., et al. Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors. J. Vis. Exp. (2021).
Copyright © 2025 MyJoVE Corporation. Todos os direitos reservados